In addition to promoting recruitment and effector function of tumor-specific CD8+ T cells, these chemokines are also able to enrich the TME of functional DC and NK cells, two key immune components associated with improved survival of both adult and pediatric cancer patients [5]. This evidence concerns the gene CD8A and cancer.